Oracle (NYSE:ORCL) executives said fiscal third-quarter 2026 results exceeded expectations “across the board,” pointing to accelerating growth in cloud applications, rapid expansion in multi-cloud ...
AI-enabled predictive intelligence solution helps organizations avoid safety incidents, reduce costs, and foster a proactive safety culture ...
Learn how to delete Calendar items in Outlook Web, MS Outlook and new Outlook app, and what to do if Outlook calendar deletes ...
If Microsoft Visual C++ Redistributable Repair is stuck because of corrupted files in the Package Cache or a hung Windows Installer service; follow these solutions to fix the issue.
Oracle's debt is rising as cash flies out the door to fund AI data centers. The company already has a debt-heavy balance sheet, and it will need to borrow more to fund its AI infrastructure contracts.
The broader AI trade is back in the hot seat because of Oracle. It shouldn't be. Oracle shares were getting crushed on Thursday following a quarterly sales miss, a disappointing guide, and a spending ...
SALINE TWP., MI - For some, it’s light pollution. For others, it’s a poor use of farmland. For still others, it’s the fast-tracked political process. On one thing, though, they all agreed: the data ...
Ascent Wealth Partners sold 26,178 shares of Oracle, an estimated $6.64 million reduction based on the quarterly average price for the period ended September 30, 2025. The trade represents 0.8% of ...
Advanced Micro Devices Inc., Nvidia Corp.’s nearest rival in AI processors, said Oracle Corp. will deploy a large batch of its forthcoming MI450 chips next year. Oracle will put 50,000 of the ...
Oracle’s Java team sat down with me last week for a fast-moving briefing on Java 25 and the broader direction of the platform. The headline: JDK 25 is an LTS release, the second on Oracle’s new ...
Oracle has released Java 25 (Oracle JDK 25), the newest version of the language and platform that has been around for over three decades. The update brings thousands of improvements, many aimed at ...